Syndax Pharmaceuticals reported an impressive $45.9 million in total revenue for the third quarter, marking a robust 21% growth compared to the previous quarter. This growth underscores the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback